Vicarious Surgical Appoints Sarah Romano as Chief Financial Officer, Bringing Decades of Financial Strategy Experience to the Role.
ByAinvest
Tuesday, Jan 13, 2026 12:16 pm ET1min read
RBOT--
Vicarious Surgical announces Sarah Romano as Chief Financial Officer, effective April 1, 2025. Romano brings decades of experience in financial strategy and corporate development, with a proven track record in fundraising and M&A initiatives. She will oversee Vicarious Surgical's financial strategy and drive growth and value creation. Romano previously served as CFO of Entero Therapeutics and Kiora Pharmaceuticals.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet